[How to reduce the risks of NSAIDs].
作者信息
Gross Manfred
机构信息
Internistische Klinik Dr Müller, München.
出版信息
MMW Fortschr Med. 2008 Jul 31;150(28-31):50-3; quiz 54.
PMID:19006892
Abstract
摘要
相似文献
1
[How to reduce the risks of NSAIDs].
MMW Fortschr Med. 2008 Jul 31;150(28-31):50-3; quiz 54.
2
[Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
MMW Fortschr Med. 2004 Mar 25;146(13):61.
3
[NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
MMW Fortschr Med. 2010 May 20;152(20):46-7.
4
Prevention of peptic ulceration in patients receiving NSAIDs.
Br J Hosp Med. 1993;49(11):767-72.
5
[Pathogen eradication prevents gastrointestinal complications].
MMW Fortschr Med. 2007 Oct 25;149(43):58-9.
6
Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
Clin Pharmacol Ther. 1997 May;61(5):503-8. doi: 10.1016/S0009-9236(97)90130-2.
7
Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
Rev Gastroenterol Disord. 2005;5 Suppl 2:39-49.
8
Helicobacter pylori and nonsteroidal anti-inflammatory drug interactions in bleeding ulcers.
Gastrointest Endosc. 2002 Oct;56(4):604-6; discussion 606-7.
9
Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Gastroenterology. 2007 Sep;133(3):790-8. doi: 10.1053/j.gastro.2007.06.058. Epub 2007 Jul 3.
10
[Prevention and therapy of non-steroidal antirheumatic drug-induced ulcers: an update].
Dtsch Med Wochenschr. 2000 Aug 18;125(33):975-8. doi: 10.1055/s-2000-7005.
Zotero 插件